Home - Products - Others - Other Targets - Thymosin β4 (human, bovine, horse, rat)

Thymosin β4 (human, bovine, horse, rat)

CAS No. 77591-33-4

Thymosin β4 (human, bovine, horse, rat)( ——— )

Catalog No. M40102 CAS No. 77591-33-4

Thymosin β4 (human, bovine, horse, rat)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Thymosin β4 (human, bovine, horse, rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    Thymosin β4 (human, bovine, horse, rat)
  • Description
    Thymosin β4 (human, bovine, horse, rat)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    77591-33-4
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Curculigoside C

    Curculigoside C is a natural product of Curculigo, Amaryllidaceae. Curculigoside C can be used as a reference standard.

  • 4-P-PDOT

    4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist.

  • PKC ζ pseudosubstrat...

    Inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by a disulphide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the inhibitor peptide. Once inside the cell, the disulphide bonds are subjected to reduction in the cytoplasm leading to release of the inhibitor peptide. Induces mast cell degranulation by a PKC ζ-independent pathway.